Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
Vous n'êtes pas connecté
UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones.
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
A type of aggressive, treatment-resistant brain tumour has a distinct population of immune cells that support its growth, according to new research...
Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumour growth by increasing cancer stemness in an oestrogen...
Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers at the Institute for...
The objects we live with become a part of our memory, profoundly influencing who we are. They help us recognize and understand our surroundings,...
Scientists in China have identified a new bat coronavirus, HKU5-CoV-2, capable of infecting humans by binding to the ACE2 receptor, similar to...
Cancer cells work together to source nutrients from their environment-a cooperative process that was previously overlooked by scientists but may be a...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have...
Colorectal cancer (CRC) is one of the deadliest cancers worldwide, and one of the biggest challenges in treating it is therapy resistance. Many...
Researchers have identified how gastric bacteria leaking through the stomach lining plays a crucial role in the onset of stomach cancer, paving the...